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Signal transduction pathwaysHepatitis C virus nonstructural protein 4B (NS4B) is an endoplasmic reticulum (ER) membrane associated
protein and a potent causative factor of ER stress. Here we reported that unfolded protein response (UPR) can
be activated by HCV NS4B through inducing both XBP1 mRNA splicing and ATF6 cleavage in human hepatic
cells. Flow cytometric analysis revealed that HCV NS4B stimulates the production of reactive oxygen species
(ROS) by perturbing intracellular Ca2+ homeostasis. Luciferase assay showed that HCV NS4B also activates
the multifunctional transcription factor, NF-κB, in a dose-dependent manner through Ca2+ signaling and
ROS. Further immunoblot analysis showed that HCV NS4B promotes NF-κB translocation into the nucleus via
protein-tyrosine kinase (PTK) mediated phosphorylation and subsequent degradation of IκBα. These studies
provide an important insight into the implication of NS4B in HCV life cycle and HCV-associated liver disease
by affecting host intracellular signal transduction pathways.© 2009 Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV), a member of the Flaviridae family, is a
major cause of chronic hepatitis, which can lead to cirrhosis and ﬁnally
hepatocellular carcinoma (Choo et al., 1989; Farci et al., 2000). Its
single-stranded RNA genome is a 9.6 kb positive sense molecule,
which carries a large open reading frame (ORF) surrounded by a 5′
and 3′ non-coding region (NCR). The single long ORF encodes a
polyprotein precursor of ∼3010 amino acids, which can be cleaved to
produce the mature structural (core, E1 and E2) and nonstructural
(NS2, NS3, NS4A, NS4B, NS5A, and NS5B) proteins (Grakoui et al.,
1993). HCV NS4B is a hydrophobic proteinwith an apparent molecular
weight of 27 kDa (Hugle et al., 2001). Structural studies showed that
NS4B is an integral membrane protein harboring at least four
predicted transmembrane domains and can reorganize intracellular
membranes into intense foci that favor viral replication (Lundin et al.,u), lingbaok@hotmail.com
hysics, and Molecular Biology,
ll rights reserved.2003; Egger et al., 2002). HCV NS4B has also been demonstrated to
inﬂuence intracellular signaling pathways to regulate gene expression
(Park et al., 2000; Zheng et al., 2005). Park et al. (2000) reported that
NS4B can transform NIH3T3 cells by inducing Ras-mediated pathway.
We have reported that HCV NS4B activates unfolded protein response
(UPR) by triggering XBP1 mRNA splicing in nonhepatic HeLa stable
transfectants (Zheng et al., 2005).
UPR is one adaptive strategy employed by cells to alleviate the ER
stress caused by various conditions such as the presence of unfolded
protein, protein accumulation, and depletion of cholesterol (Pahl,
1999a). Under stress conditions, UPR can be evoked by activating the
activating transcription factor 6 (ATF6), IRE1-XBP1 (X-box binding
protein) and PER-like ER kinase (PERK) pathways, which lead to the
following events: (1) transcription of ER chaperon proteins and
folding enzymes, (2) ER-related protein degradation, (3) translational
attenuation (Harding et al., 1999; Shen et al., 2002; Lee et al., 2003). In
response to ER stress, cells can also activate another related signal
transduction pathway, ER overload response (EOR) (Pahl, 1999a). EOR
can be easily elicited by overexpression or accumulation of ER
membrane localized proteins. Ca2+ is released from ER lumen and
taken up by mitochondria, which triggers local oxidative stress and
production of radical oxygen species (ROS). As a result of changes in
Fig. 1. HCV NS4B induces both XBP1 mRNA splicing and ATF6 cleavage. A. RT-PCR
analysis of XBP1 spliced and unspliced mRNA. Total RNA was extracted from NS4B-
expressing, empty vector transfected and tunicamycin treated cells and subjected to RT-
PCR using XBP1-speciﬁc primers that generate the 416-bp spliced XBP1 mRNA
designated XBP1(s) and 442-bp unspliced XBP1 mRNA designated XBP1 (u) (upper
panel). GAPDH was ampliﬁed as internal loading control (lower panel). The PCR
products were subjected to 2% agarose gel electrophoresis. The bands corresponding to
XBP1 (u), XBP1 (s), and GAPDH are indicated by arrowheads. B. Immunoblot analysis of
XBP1 expression and ATF6 cleavage using antibodies against XBP1 (upper panel) and
ATF6 (middle panel). The actin protein band in the same immunoblot was used as an
internal loading control (lower panel). Samples analyzed in (A) and (B) are: lanes 1 and
7, Hep3B and Huh7 cells stably transfected with pcDNA3.1 (−) NS4B; lanes 2 and 8,
Hep3B and Huh7 cells transiently transfected with pcDNA3.1 (−) NS4B; lanes 3 and 9,
Hep3B and Huh7 stably transfected with pcDNA3.1 (−); lanes 4 and 10, Hep3B and
Huh7 cells transiently transfected with pcDNA3.1 (−); lanes 5 and 11, Hep3B and Huh7
cells stably transfected with pcDNA3.1 (−) and treated with tunicamycin (2.5 μg/ml)
for 6 h; lanes 6 and 12, Hep3B and Huh7 cells transiently transfected with pcDNA3.1
(−) and treated with tunicamycin (2.5 μg/ml) for 6 h.
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factor κB (NF-κB) is activated (Meyer et al., 1992; Pahl and Baeuerle,
1995; Gong et al., 2001).
Nuclear factor κB (NF-κB) is a sequence speciﬁc transcription factor
that regulates the expression ofmany cellular and viral genes and plays
important roles in immune responses, cell growth and survival (Karin
and Lin, 2002; Santoro et al., 2003). In mammals, NF-κB family con-
tains ﬁve members: NF-κB1 (p105 and p50), NF-κB2 (p100 and p52),
RelA (p65), RelB, and c-Rel (Ghosh et al.,1998). Among thesemembers,
heterodimer p50/p65 is the most abundant form and commonly
referred as NF-κB. In resting cells, NF-κB is sequestered in the cyto-
plasm by binding to inhibitory proteins of the IκB family, including
IκBα, IκBβ, IκBɛ (Karin and Ben-Neriah, 2000). After exposure to a
variety of pathological stimuli such as bacterial and viral infections,
ultraviolet and inﬂammatory cytokines, IκBα is phosphorylated by IκB
kinases (IKKα and IKKβ) and followed by degradation by 26S pro-
teasome. The released active form of NF-κB then translocates into the
nucleus and initiates transcription of genes participating in regulation
of the host immune and inﬂammatory response such as cyclooxy-
genase 2 (COX2), nitric oxide synthase (iNOS) and pro-inﬂammatory
cytokines (Karin and Ben-Neriah, 2000; Pahl, 1999b). An alternative
mechanism for NF-κB activation involves phosphorylation of IκBα at
Tyr42, Tyr305, and PEST (Pro-Glu-Ser-Thr) sequences under oxidative
stress. Tyrosine-phosphorylated IκBα can be degraded and results
in the dissociation of NF-κB from its inhibitory complex (Schoonbroodt
et al., 2000; Livolsi et al., 2001; Waris et al., 2003).
HCV replication has been shown to cause ER stress and its gene
products such as Core, E2, and NS5A, have also been demonstrated to
induce UPR or EOR (Benali-Furet et al., 2005; Chan and Egan, 2005;
Gong et al., 2001; Tardif et al., 2002; Sir et al., 2008). In this paper, we
reported that another HCV gene product, NS4B, can activate both UPR
and EOR pathways in response to ER stress. By transiently or stably
expressing NS4B in different human hepatic cell lines, we observed
the truncated active form of ATF6 (p50ATF6) as well as previously
reported spliced XBP1 mRNA. We further demonstrated that NS4B
elicits the EOR pathway by altering the intracellular Ca2+ homeostasis
and stimulating the production of radical oxygen species (ROS), which
leads to activation of NF-κB. Finally, we showed that NS4B activates
NF-κB via protein-tyrosine kinase (PTK)-mediated tyrosine phosphor-
ylation and subsequent degradation of IκBα. These altered intracel-
lular events by HCV NS4B may ultimately address its role in HCV life
cycle and liver pathogenesis associated with HCV infection.
Results
HCV NS4B induces both XBP1 mRNA splicing and ATF6 cleavage in
human hepatic cells
Under ER stress conditions, XBP1 mRNA can be spliced by
endoribonuclease IRE1 (27). Our previous results indicated that
NS4B activates XBP1 mRNA splicing in HeLa stable transfectants of
nonhepatic origin (Zheng et al., 2005). Since HCV has a narrow host
organ range and its replication was primarily detected in human liver
(Zhu et al., 2003), we therefore examined the effect of NS4B on XBP1
mRNA splicing in human hepatic cell lines, Hep3B, Huh7 and HepG2
cells. XBP1 mRNA splicing was analyzed by Reverse transcription PCR
(RT-PCR) using XBP1-speciﬁc primers. In agreement with previous
reports, we detected the 416-bp fragment ampliﬁed from spliced XBP1
mRNA (XBP1(s)) in Huh7, Hep3B and HepG2 cells transiently
transfected with NS4B expression plasmid (Fig. 1A, lanes 2 and 8;
Fig. S2A, upper panel, lane 2). Only the 442-bp fragment corres-
ponding to the unspliced XBP1mRNAwas detected in cells transiently
transfected with empty vector (Fig. 1A, lanes 4 and 10; Fig. S2A, upper
panel, lane 1). To further examine whether constitutive expression of
NS4B protein could perform the same function in human hepatic cells,
we generated Hep3B, Huh7 and HepG2 cell lines stably expressingNS4B. The integration of NS4B gene into the genome of stably
transfected cells was conﬁrmed by genomic PCR and the expression of
NS4B protein was detected by immunoblot (Fig. S1). Our RT-PCR
analysis showed that XBP1(s) occurs in cells stably transfected with
NS4B expression plasmid but not in cells stably transfected with
empty vector (Fig. 1A, compare lanes 1 and 7 with lanes 3 and 9). As
positive controls, the same XBP1(s) fragment was detected in cells
treated with tunicamycin, a compound causes ER stress by inhibiting
protein N-glycosylation (Kaufman, 1999) (Fig. 1A, lanes 5, 6, 11 and
12). Further immunoblot analysis using speciﬁc antibody against XBP1
demonstrated that the spliced XBP1 protein (XBP1(S)) was only
present in NS4B-expressing cells (Fig. 1B, upper panel, lanes 1, 2, 7 and
8) and tunicamycin treated cells (Fig. 1B, upper panel, lanes 5, 6, 11
and 12), suggesting that spliced XBP1 mRNA is translated into XBP1
(S) protein in cells expressing NS4B. Intriguingly, we detected a higher
ratio of spliced XBP1 to unspliced XBP1 in hepatic cell lines than
nonhepatic HeLa cells especially at the protein level (compare Fig. 3C
in Zheng et al., 2005 with Fig. 1B), suggesting that HCV NS4B exerts
pronounced effects in hepatic originated cells.
We then investigated whether NS4B could activate ATF6 proteolysis
pathway, another branch pathway of UPR. ATF6 is constitutively
expressed as a 90 kDa proteins (p90ATF6), which is proteolytically
cleaved into a 50 kDa active transcription factor (p50ATF6) upon ER
stress (Shen et al., 2002; Yoshida et al., 2001a, 2001b). Immunoblot
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the presence of the truncated form p50ATF6 in the Hep3B and Huh7
cells stably or transiently transfectedwithNS4B expressionplasmid, but
not in empty vector transfected cells (Fig. 1B, middle panel, compare
lanes 1, 2, 7 and 8 with lanes 3, 4, 9 and 10), indicating that ATF6 is
processed into its mature form in response to ER stress caused by
transientor stable expressionofNS4B. The same experimentwas carried
out using Hep3B cells stably expressing NS2 or NS5B. However, neither
of them induced the production of p50ATF6 (data not shown), which
conﬁrmed that activated ATF6 cleavage is speciﬁcally induced by NS4B.
HCV NS4B induces Ca2+ signaling and ROS production
In addition to UPR, ER stress has also been reported to trigger ER
overload response (EOR) pathway (Pahl, 1999a). To examine the
function of NS4B in EOR pathway, we measured the level of reactive
oxygen species (ROS) by ﬂow cytometric analysis (Gong et al., 2001).
Transfected cells were stained with dihydroethidium (DHE), which can
beoxidized to ethidiumby superoxide radicals and intercalatewithDNA
in the nucleus, where it emits ﬂuorescence at 605 nm. As described in
Fig. 2A, more ROS production was detected in cells transiently
transfected by pcDNA3.1 (−) NS4B than cells transfected by pcDNA3.1
(−). What is more, ROS production is stimulated by NS4B in a dose-Fig. 2. HCV NS4B activates ROS production through Ca2+ signaling. A. Dose-dependent
production of ROS in cells transiently transfected with NS4B expression plasmid. Hep3B
and Huh7 cells were co-transfected with different amounts of pcDNA3.1 (−) NS4B and
pcDNA3.1 (−). 48 h post-transfection cells were then treated with 4 μMDHE for 45 min
and harvested for ﬂow cytometric analysis of cellular ROS levels. All experiments were
conducted with triplicate samples. Bars show standard deviation (S.D) of the mean
(n=3). ⁎, Pb0.05. B. Flow cytometric analysis of ROS levels in Ca2+ chelators treated
Hep3B and Huh7 stable transfectants. ROS levels were measured after treating cells
with BAPTA-AM for 2 h or TMB-8 for 4 h as indicated. All experiments were repeated
three times. Bars show standard deviation (S.D) of the mean (n=3). ⁎, Pb0.05.
Fig. 3.HCVNS4B activatesNF-κB inadose-dependentmanner. A. Luciferase assay showing
the activity of NF-κB in NS4B transiently transfected cells. Hep3B and Huh7 cells were co-
transfectedwith a total 0.4 μgof plasmids consistingof 0–0.4 μgof pcDNA3.1 (−) NS4B and
pcDNA3.1 (−), 0.1 μg of pNF-κB-Luc, and 0.001 μg of pRL-CMV. Cells were treated with
thapsigargin (0.4 μM) or untreated for 4 h before harvesting the cells at 48 h post-
transfection for luciferase assay. Bars show standard deviation (S.D) of the mean (n=3).
⁎, Pb0.05. B. Luciferase assay showing the activity of NF-κB in stable transfectants. Hep3B
and Huh7 stable transfected cells were co-transfected with 0.1 μg of pNF-κB-Luc and
0.001 μg of pRL-CMV. Cells were treated with thapsigargin (0.4 μM) or untreated for 4 h
before harvesting the cells for luciferase assay. All experiments were conducted with
triplicate samples. Bars show standard deviation (S.D) of the mean (n=3). ⁎, Pb0.05.dependentmanner as increased ROS level was observed in the presence
of increasing amount of pcDNA3.1 (−) NS4B. In the Hep3B and Huh7
cells stably expressing NS4B, there is a signiﬁcant increase (2.3-fold and
2.8-fold respectively) in the level of ROS (Fig. 2B), which suggests that
NS4B is involved in ROS production. To evaluate the requirement of
intracellular calcium signaling in NS4B-stimulated ROS production,
similar experiment was performed in the presence of Ca2+ chelator,
BAPTA-AM and TMB-8 (Pahl and Baeuerle, 1996). As expected, NS4B-
induced ROS production was remarkably reduced in chelators treated
Hep3BandHuh7stable transfectants (Fig. 2B), demonstrating thatNS4B
is capable of stimulating ROS production through Ca2+ signaling in
human hepatic cells.HCV NS4B induces NF-κB activation
Since EOR pathway has been shown to activate NF-κB pathway (Pahl
and Baeuerle, 1995), we hypothesized that NS4B protein could activate
the NF-κB pathway in human hepatic cells. To test this hypothesis,
luciferase assay was performed using NF-κB-inducible reporter plasmid,
pNF-κB-Luc, a luciferase expression vector under the transcriptional
Fig. 5. HCV NS4B does not alter the total amount of NF-κB but facilitates their nuclear
translocation. A. Immunoblot analysis of p65 and p50 in whole cell lysates from Hep3B
and Huh7 stable transfectants using the antibodies against p65 and p50. Actin protein
bands act as internal loading control. The bands corresponding to p65, p50, and actin
are indicated by arrowheads to the right of gels. B. Immunoblot analysis of p65 and p50
in cytoplasmic and nuclear fractions prepared from stably transfected Hep3B (left
panel) and Huh7 (right panel) cells. YY1 acts as a nuclear-speciﬁc control and GAPDH as
a cytoplasmic-speciﬁc control. Results are representative of three independent
experiments.
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2001b). As described in Fig. 3A, luciferase activity was signiﬁcantly
increased by transfecting cells with increasing amount of NS4B
expression plasmid, pcDNA3.1 (−) NS4B. NS4B stably expressing cells
were also analyzed by luciferase assay. As observed in transient
transfectants, luciferase activity was increased dramatically (4.2-fold for
Hep3B cells and 6.1-fold for Huh7 cells) in NS4B stably expressing cells,
comparable with the cells treated with thapsigargin, which has been
shown to activate NF-κB (Pahl, 1999b) (Fig. 3B). These results suggest a
direct involvement of NS4B in NF-κB activation in human hepatic cells.
HCV NS4B-induced NF-κB activation depends on both Ca2+ signaling
and ROS production
In order to investigate whether NS4B-induced NF-κB activation
was dependent on Ca2+ signaling, Hep3B and Huh7 cells stably
expressing NS4B were treated with Ca2+ chelators, BAPTA-AM for 2 h
or TMB-8 for 4 h. Luciferase assay showed that NF-κB regulated
expression was signiﬁcantly reduced after exposure to Ca2+ chelators
(Fig. 4). To investigate whether ROS accumulation is required for
NS4B-induced NF-κB activation, antioxidant reagents, N-acetyl L-
cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC), were
employed in this study. As shown in Fig. 4, NS4B-induced NF-κB
activation was completely abolished by treating cells with NAC or
PDTC. Thus, NS4B activates NF-κB by disturbing Ca2+ homeostasis and
subsequent accumulation of ROS.
To further explore the molecular mechanism of NS4B-induced NF-
κB activation, we examined the total quantity of NF-κB in transfected
cells by immunoblot with antibodies speciﬁc for its subunits, p50 and
p65. Interestingly, neither p50 nor p65 was affected by constitutive
expression of NS4B in Hep3B and Huh7 cells, arguing that NS4B has
little or no effect on the expression and stability of NF-κB (Fig. 5A).
Previous studies have shown that activated NF-κB heterodimmer
(p50/p65) dissociates from the inhibitory complex and translocates into
thenucleuswhere it activates transcriptionof various target genes (Karin
Ben-Neriah, 2000). To investigate the localization of NF-κB, cytoplasmicFig. 4. Ca2+ signaling and ROS production are involved in NS4B-induced NF-κB
activation. Luciferase assay was performed after treating Hep3B and Huh7 stable
transfectants with the following Ca2+ chelators or antioxidants: BAPTA-AM (50 μM) for
2 h, TMB-8 (100 μM) for 4 h, NAC (30mM) for 8 h, PDTC (100 μM) for 8 h as indicated. At
least three independent experiments were performed and bars show standard
deviation (S.D) of the mean (n=3).and nuclear fractionswere prepared and analyzed by immunoblot using
antibodies speciﬁc for p50 and p65. As controls, nucleus-speciﬁc
antibody against YY1 and cytoplasmic-speciﬁc antibody against
GAPDH were used to preclude cross contamination. Our results showed
that in Hep3B and Huh7 cells stably expressing NS4B, a large portion of
p50 and p65 was detected in the nucleus and a small portion in the
cytoplasm (Fig. 5B). In empty vector transfected cells, almost all the p50
and p65 proteins appeared in the cytoplasm. These results document
that NS4B activates NF-κB by facilitating p50/p65 heterodimer move-
ment into thenucleus. Similar resultswere alsoobserved inHep3B,Huh7
and Hep2G cells transiently expressing NS4B (data not shown).HCV NS4B induces PTK-mediated tyrosine phosphorylation and
subsequent degradation of IκBα
Under oxidative stress, NF-κB can be activated by phosphorylation
of IκBα at Tyr42, Tyr305 and PEST (Pro-Glu-Ser-Thr) sequences
(Schoonbroodt et al., 2000; Livolsi et al., 2001; Waris et al., 2003).
The phosphorylation status of IκBα was analyzed by immunoblot
using antibody recognizing IκBα phosphorylated at Tyr-42 (phospho-
IκBα (Tyr-42)). We detected the presence of tyrosine-phosphorylated
IκBα (p-Tyr-IκBα) in Hep3B and Huh7 cells either stably or transiently
transfected with NS4B expression plasmid (Fig. 6A, lanes 1, 2, 5 and 6).
However, we failed to detect tyrosine-phosphorylated IκBα in
Hep3B and Huh7 cells transfected with empty vector (Fig. 6A, lanes
3, 4, 7 and 8). To evaluate whether phosphorylation of IκBα was
carried out by protein-tyrosine kinase (PTK), two known PTK-speciﬁc
inhibitors, piceatannol and herbimycin, were used in the same ana-
lysis (34). These two reagents substantially reduced the level of
tyrosine-phosphorylated IκBα in NS4B-expressing cells (Fig. 6B,
compare lanes 2, 3, 7 and 8 with lanes 1 and 6). In contrast, IKK
inhibitor (BAY11-7085) had no effect on the total level of tyrosine-
phosphorylated IκBα (Fig. 6B, compare lanes 4 and 9with lanes 1 and 6),
Fig. 6. HCV NS4B induces tyrosine phosphorylation and subsequent degradation of
IκBα. A. Immunoblot analysis of IκBα in NS4B-expressing and empty vector transfected
cells using anti-phospho-IκBα (Tyr-42) antibody (upper panel) and anti-IκBα antibody
(middle panel). Actin protein bands act as internal loading controls (lower panel). Lanes
1 and 5, Hep3B and Huh7 stably transfected with pcDNA3.1 (−) NS4B; lanes 2 and 6,
Hep3B and Huh7 cells transiently transfected with pcDNA3.1 (−) NS4B; lanes 3 and 7,
Hep3B and Huh7 stably transfected with pcDNA3.1 (−); lanes 4 and 8, Hep3B and Huh7
cells transiently transfected with pcDNA3.1 (−). B. Immunoblot analysis of tyrosine-
phosphorylated IκBα in Hep3B and Huh7 stable transfectants in the presence of PTKs
inhibitors. Stably transfected Hep3B and Huh7 cells were treated with piceatannol
(150 μM) for 0.5 h, herbimycin A (2 μM) for 12 h, or BAY 11-7085 (10 μM) for 1 h before
harvesting the cells for immunoblot analysis with anti-phospho-IκBα (Tyr-42)
antibody (upper panel) and anti-actin antibody (lower panel). Results are representa-
tive of three independent experiments.
Fig. 7.HCVNS4B activates NF-κB via tyrosine phosphorylation of IκBα. Hep3B and Huh7
cells stably (A) or transiently (B) expressing NS4B were treated with PTKs or IKKs
inhibitors before harvesting the cells for luciferase assay as described in experimental
procedures. At least three independent experiments were performed and bars show
standard deviation (S.D) of the mean (n=3).
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phosphorylation of IκBα.
We next examined whether IκBα was degraded after being
phosphorylated by PTKs. The total amount of IκBα was analyzed by
immunoblot using antibody against IκBα. As shown in Fig. 6A, lower
level of IκBα was present in NS4B-expressing cells compared with
empty vector transfected cells, suggesting that NS4B induces
degradation of IκBα via its tyrosine phosphorylation. Taken these
observations together, it is reasonable to conclude that NS4B promotes
IκBα degradation by PTK-mediated tyrosine phosphorylation of IκBα.
HCV NS4B induces NF-κB activation through PTK-mediated tyrosine
phosphorylation of IκBα
To determine whether PTK-mediated phosphorylation of IκBα is
required for NS4B-induced NF-κB activation, the above two PTK-speciﬁc
inhibitors were employed in luciferase assay using NF-κB-inducible
reporter plasmid. As shown in Fig. 7, PTK inhibitors (piceatannol and
herbimycin) effectively reduced the NS4B-induced NF-κB activity.
However, little effect was observed by treating transfected cells IKK
inhibitor (BAY11-7085) (Figs. 7A and B). Collectively, these results
suggest that HCV NS4B activates NF-κB by PTK-mediated tyrosine
phosphorylation of IκBα followed by degradation of IκBα, while serine
IκBα kinases (IKK) are not required for the whole process.
Discussion
HCV replicates from a ribonucleoprotein (RNP) complex that is
associated with the ER membrane (Hijikata et al., 1993; Moradpour et
al., 1998). Its replication activities cause ER stress and induce UPR by
activating three different sensors: PERK, ATF6 and IRE1 (Tardif et al.,
2002; Sir et al., 2008). Two of HCV structural proteins, Core and E2,
have also been shown to induce UPR (Benali-Furet et al., 2005; Chan
and Egan, 2005). HCV NS4B, an ER-membrane associated protein, can
cause the morphological changes of the ER membrane (Lundin et al.,
2003; Egger et al., 2002; Gretton et al., 2005). HCV NS4B has also been
reported to interact with transcription factor ATF6β (Tong et al.,2002). It is tempting to speculate that its expression or its association
with ER membrane could cause ER stress and elicit relevant signaling
transduction pathways. Here, we showed that UPR can be activated by
HCV NS4B through inducing XBP1 mRNA splicing and ATF6 cleavage
(Fig. 1). Furthermore, this activation effect was not limited to certain
cell types as similar results were observed in three different hepatic
cell lines and one nonhepatic cell lines (Fig. 1; Fig. S2; Zheng et al.,
2005). Nevertheless, these results argue that hepatic cells are more
authentic than nonhepatic cells to study the functions of HCV NS4B as
strong XBP1 mRNA splicing was observed in hepatic cells, which is
consistent with limited host organs for HCV replication. ATF6
undergoes cleavage to form active transcription factors to initiate
the expression of chaperone proteins that restore the folding of
proteins in the ER lumen (Shen et al., 2002). Among these chaperone
proteins, glucose-regulated protein-78 (GRP78) has been found to be
activated by NS4B expression (data not shown), whichmight help fold
NS4B protein to alleviate the damage to the ERmembrane. In addition,
UPR induced by HCV has been reported to play a positive role in HCV
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propagation as abrogation one of three UPR pathways can suppress
HCV replication signiﬁcantly (Sir et al., 2008). Hence, it is reasonable
to propose that the UPR induced by HCV NS4B alone or in cooperation
with other HCV proteins contributes to HCV infection by relieving cells
from stress conditions and facilitating replication.
Interestingly, HCV NS4B also activates another ER stress response,
EOR, which has been reported to be activated either by HCV
subegenomic replicon or NS5A alone. Expression of NS5A perturbs
the intracellular calcium signaling pathway and elevates the ROS in
mitochondria, which ultimately lead to activation of transcription
factors such as NF-κB and STAT (Gong et al., 2001). Similar mechanism
for activation of NF-κB via calcium signaling and ROS accumulation has
also been reported in HCV-expressing cells (Waris et al., 2003; Waris
and Siddiqui, 2005). By employing similar technique, our data clearly
indicate that expression of NS4B leads to a remarkable increase in the
level of reactive oxygen species (ROS) (Fig. 2). This stimulation of ROS
generation was also shown to be dependent on the Ca2+ signaling
pathway as NS4B-stimulated ROS production was dramatically
reduced by treating with Ca2+ chelators (Fig. 2B). As a result of EOR
activation, NF-κB was activated in Hep3B and Huh7 cells expressing
NS4B (Fig. 4), which is consistent with the results conducted in HeLa
cells expressing NS4B (Kato et al., 2000). Waris et al. (2003) reported
that HCV NS5A-induced NF-κB activation involves PTK-mediated
phosphorylation of IκBα at Tyr42 and Tyr305 and subsequent degrada-
tion. Our results indicated that HCV NS4B induces PTK-mediated
tyrosine phosphorylation of IκBα, IκBα degradation, NF-κB transloca-
tion and ultimate NF-κB activation (Figs. 5, 6 and 7). It remains to be
determinedwhether the phosphorylation of Tyr42 and Tyr305 of IκBα is
required for the HCV NS4B-induced NF-κB activation.
ROS is a potent causer of cancer as it can lead to oxidative damage of
DNA, protein and lipids, facilitating DNAmutagenesis and tumor growth
(Tardif et al., 2002). Accumulation of ROS in cells causes oxidative stress,
which plays an important role in malignant diseases and chronic
inﬂammation, and increased level of ROS has been reported in the livers
of patients chronically infected with hepatitis C virus (Kaufman, 1999;
Pahl,1999a). The activated EOR pathway in NS4B-expressing cells might
establish its contribution to liver disease caused by HCV infection.
Activated NF-κB activates the transcription of genes involved in immune
system and inﬂammatory response, such as cyclooxygenase 2 (COX2),
TNF-α and IL-1, IL-2, IL-6, IL-8, IL-12 (Pahl, 1999b). Hepatitis C virus has
been reported to stimulate the expression of cyclooxygenase 2 (COX2)
via ROS production and subsequent activation of NF-κB (Waris and
Siddiqui, 2005). Elevated COX2 is implicated in inﬂammation, and
tumorigenesis including hepatocellular carcinoma. Whether NS4B-
induced NF-κB regulates the expression of genes involved in the
inﬂammatory response and tumorigenesis is under further investigation.
Although the activity of NS4B in ER membrane has been reported
to provide sites for HCV replication, here we provided compelling
evidence that the expression or association of NS4B in ER causes ER
stress followed by activating both the UPR and EOR pathways, as have
been documented for a number of viral proteins associated with ER
membrane (Meyer et al., 1992; Pahl and Baeuerle, 1995). We also
provided a plausible mechanism for NF-κB activation by HCV NS4B.
This cascade of altered intracellular events by expression of HCV NS4B
implicates its potential role in HCV infection and the associated liver
disease. Meanwhile, blockage of these two pathways may provide
important clues to the development of drugs to prevent HCV infection
and treat HCV-associated liver disease.
Materials and methods
Plasmids and antibodies
NF-κB-inducible reporter plasmid (pNF-κB-Luc) was purchased
from Stratagene. Empty vector pcDNA3.1 (−) and HCV NS4Bexpression plasmid (pcDNA3.1 (−) NS4B), were obtained as described
previously (Zheng et al., 2005). The polyclonal antibody against ATF6
was prepared according to standard protocol with little modiﬁcations
(Timani et al., 2004). Human ATF6 cDNA (GenBank accession no.
AB015856) corresponding to the amino acids 1–192 was ampliﬁed
from RNA isolated from HeLa cells by RT-PCR and cloned into
prokaryotic expression vector pET-His (Invitrogen). The forward and
reverse primers used are: 5′-GGT ACC GAA TTC AGG ATG AAC CCT AGT
GTG GGA CCT-3′; 5′-GGT ACC AAG CTT CTC CCC TTC TGC GGA TGG C-3′.
The recombinant plasmid was conﬁrmed by DNA sequencing. Recom-
binant ATF6 (1–192) protein was expressed in BL21 (DE3) and puriﬁed
by Ni-NTA afﬁnity column (Stratagen). The purity of protein was
examined by electrophoresis on 15% SDS-PAGE. The puriﬁed ATF6
(1–192) protein was then immunized rabbit to generate anti-ATF6
polyclonal serum. The reactivity and speciﬁcity of antibody were
examined by immunoblot analysis. All other antibodies and reagents
used are described in the Supplemental data.Cell lines and transfection
Human hepatic cell lines Hep3B, HepG2, and Huh7 were obtained
from China Centre for Type Culture Collection (Wuhan, China). Cells
were maintained in Dulbecco's modiﬁed Eagle's medium (Gibco-BRL,
USA), supplemented with 10% heat-inactivated fetal bovine serum
(Hyclone), 100 units/ml penicillin, and 100 μg/ml streptomycin. After
incubating for 12 h, the cells were transfected with 0.5 μg pcDNA3.1
(−) NS4B or pcDNA3.1 (−) using Lipofectamine 2000 reagent kit
(Invitrogen) according to the manufacturer's instructions. To con-
struct Hep3B, HepG2 and Huh7 cell lines stably expressing NS4B, the
medium was replaced with DMEM containing 300 μg/ml of G418 at
24 h post-transfection. About 3 weeks later, individual G418-resistant
colonies were isolated, expanded and conﬁrmed by genomic PCR
using NS4B speciﬁc primers and immunoblot analysis using anti-NS4B
monoclonal antibody as described in the Supplemental data. For
reagent treatment experiments, transfected cells were treated
tunicamycin (2.5 μg/ml) for 4 h, thapsigargin (0.4 μM) for 4 h, NAC
(30 mM) for 8 h, PDTC (100 μM) for 8 h, TMB-8 (100 μM) for 4 h,
BAPTA-AM (50 μM) for 2 h, piceatannol (150 μM) for 0.5 h, herbimycin
A (2 μM) for 12 h, BAY 11-7085 (10 μM) for 1 h before harvesting the
cells.Reverse transcription PCR
Total RNA was extracted using Trizol reagent (Invitrogen). The
cDNA strand was synthesized using AMV-reverse transcriptase kit
(Takara). To detect the spliced and unspliced XBP1 mRNA, XBP1-
speciﬁc primers were used as described previously (Yoshida et al.,
2001a, 2001b). PCR products were electrophoresed on 2% agarose gel.
GAPDHwas used as an internal control as described previously (Zheng
et al., 2005).Protein extraction and western blot analysis
Total cell extracts were prepared by incubating cells in lysis buffer
(0.3% NP40, 1 mM EDTA, 50 mM Tris–Cl, pH 7.9, 2 mM EGTA, 1% Triton
X-100, 150 mM NaCl, 25 mM NaF, 1 mM Na3VO3, 10 μg/ml PMSF) for
30min on ice and subsequent centrifugation at 12,000 rpm for 15min.
Protein samples were separated by SDS-PAGE and transferred to
nitrocellulose membranes. The blots were probed with the primary
antibodies against HCV NS4B, ATF6, XBP1, p65, p50, phospho-IκBα
(Tyr-42), IκBα, YY1, GAPDH and actin proteins. Next, horseradish
peroxidase-labeled goat anti-rabbit IgG as secondary antibodies were
applied onto the blots. The speciﬁc proteins were visualized by using
the ECL Chemiluminescence Detection Kit (Amersham Biosciences).
263S. Li et al. / Virology 391 (2009) 257–264Preparation of cytoplasmic and nuclear fractions
Cytoplasmic and nuclear fractions were prepared as described with
little modiﬁcations (Rosner et al., 2007). Brieﬂy, stably transfected cells
were incubated in hypotonic buffer (10 mM HEPES, pH 7.9, 5 mM KCl,
1.5 mMMgCl2, 1 mM NaF, and 1 mM Na3VO4, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl ﬂuoride, 2 mg/ml aprotonin, 2 mg/ml leupeptin,
and 37.5 mg/ml soybean trypsin inhibitor) for 15 min on ice, the
cytoplasmic fractionwaspreparedbycentrifugationat3000 rpmfor5min
and then clearedbycentrifugation at 13,000 rpmfor15min. The cell pellet
waswashedwith thehypotonic buffer three times and suspended inhigh-
salt buffer (hypotonic buffer supplemented with 420 mM NaCl and 25%
glycerol (vol/vol)). The suspended cell pelletwas incubated for 30min on
ice with occasional vortexing, and the nuclear fractionwas collected after
centrifugation at 13,000 rpm for 10min. Protein sampleswere resolvedon
SDS-PAGE and analyzed by immunoblot.Luciferase assay
Approximately 3×105 cells were plated on a 24-well tissue culture
plates 24 h before transfection. To examine the effect of stable
expression of NS4B on NF-κB, stably transfected cells were co-
transfected with pNF-κB-Luc (0.1 μg/well) and pRL-CMV (0.001 μg/
well) (used for normalization). The transfectants were then treated
with indicated reagents or untreated before harvesting at 48 h post-
transfection. Luciferase activity was measured by the dual-luciferase
assay system (Promega) according to the protocol recommended by
the manufacturer. The ﬁreﬂy luciferase activity was normalized to the
Renilla luciferase activity and expressed as relative light units. To
examine the dose-dependent effect of NS4B on the NF-κB activation,
Hep3B and Huh7 cells were co-transfected with 0–0.4 μg of pcDNA3.1
(−) NS4B, 0.1 μg of pNF-κB-Luc, 0.001 μg of pRL-CMV and 0–0.4 μg
pcDNA3.1 (−) adjusted to a total of 0.4 μg.Flow cytometric analysis of intracelluar ROS levels
Stably or 48 h post-transiently transfected cells were incubated
with 4 μMdihydroethidium (DHE) for 45min at 37 °C. Cells were then
harvested and washed two times with PBS buffer. The ROS levels were
analyzed using an XL00W42322 ﬂow cytometer with an excitation
emission at 605 nm. Each experiment was performed independently
for three times and data were represented as the mean±S.D.Statistical analysis
The method of relative quantiﬁcation was used for luciferase assay
and ﬂow cytometric analysis of cellular ROS levels. Statistical analysis
was performed using the Statistical Package Social Sciences (SPSS)
program version 11.5 by one-way analysis of variance (ANOVA) and
signiﬁcant differences among groups were determined by Least
Signiﬁcant Difference (LSD). The accepted level of statistical sig-
niﬁcance was Pb0.05.Acknowledgments
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